Brainstorm Cell Therapeutics: MSC-NTF Cell Therapy Shows Mid-Stage Promise In PMS
I rate Brainstorm Cell Therapeutics stock as a “hold” with a positive outlook. Here is my analysis on this biotechnology company.
I rate Brainstorm Cell Therapeutics stock as a “hold” with a positive outlook. Here is my analysis on this biotechnology company.
FuboTV (FUBO) is snowballing in the underserved market of sports streaming, with the potential to enable great sports betting synergies.
Zoom could actually be a post-Covid darling opposite of what everybody thinks. The company reports earnings on 1 June. Here’s why I think there is much more upside…
The market is completely underestimating the earnings that LendingClub can generate from holding prime personal loans. Here is why I am so bullish on the stock.
The EPS exchange-traded fund presents an alternative to the market-cap weighted SPY. Click here to see which is a better option for less risk averse and risk averse…
Pfizer brought its mRNA COVID vaccine to the market, but with no impact on its stock price. This makes Pfizer stock an interesting investment. Here’s why.
CNX Resources stock has underperformed the market in relation to peers the last few months. We discuss some possible reasons for this occurrence.
EPD faces strong tailwinds with tight demand for commodities and a super-charged economy. It boasts 22 years of consistent distribution hikes and 1.6 times distribution…
Despite recent uncertainty, Iovance made a huge comeback announcing superb data for its lead franchise, lifileucel. Read more on why I believe IOVA stock has more…
Cimarex Energy (XEC) all-stock merger with Cabot Oil & Gas (COG) didn’t get the reception the companies likely expected after it was unveiled on Monday.No less…